INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 454m ago
House PTR53m ago
SEC 13F53m ago
Robinhood Chain53m ago

Results

82,103 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$60K
652 sh
Dec 16, 2025Dec 18, 2025
Page 1832 of 2053
← PrevNext →
traded Dec 16, 2025
+2d
SEC Form 4

Evidence

8
SA
Singleton Philip Austin Jr.Director, Executive Chairman, See Remarks
ONEWOneWater Marine Inc.
Gift
G—
16.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

7
HK
Hohenstein KenChief Revenue Officer
OSOneStream, Inc.
Option exercise · 10b5-1 plan
M—
30.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

7
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M—
50.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

7
HK
Hohenstein KenChief Revenue Officer
OSOneStream, Inc.
Open-market sale · 10b5-1 plan
SELL$688K
40.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

7
SS
Sharan SharatDirector, President and Chief Executive, 10% Owner
ONTFON24 INC.
Option exercise · 10b5-1 plan
M—
28.9K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

6
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Gift · 10b5-1 plan
G—
85.0K sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
285 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
181 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$19K
181 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$3,948
69 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
MJ
McVeety Kristen JGC and Secretary
CRWVCoreWeave, Inc.
Option exercise
M—
20.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
MK
McCarthy Brian K.Pres.,Global Sales & Field Ops
RBRKRubrik, Inc.
Derivative conversion
C—
6,250 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
69 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M$18K
285 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
MK
McCarthy Brian K.Pres.,Global Sales & Field Ops
RBRKRubrik, Inc.
Option exercise
M—
6,250 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise
M—
1,194 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
MK
McCarthy Brian K.Pres.,Global Sales & Field Ops
RBRKRubrik, Inc.
Derivative conversion
C—
6,250 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
RJ
Rubino Andrew JChief Operating Officer
TFSLTFS Financial CORP
Grant or award
A—
14.3K sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

5
TA
Thornock Tai A.Chief Accounting Officer
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$25K
1,100 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

5
GS
Ganesan SatishSee Remarks
SYNASYNAPTICS Inc
Tax withholding
F$11K
146 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

5
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
232 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

5
MK
McCarthy Brian K.Pres.,Global Sales & Field Ops
RBRKRubrik, Inc.
Option exercise
M—
6,250 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

4
SK
Sadowsky KennethDirector
COCOVita Coco Company, Inc.
Open-market sale · 10b5-1 plan
SELL$201K
3,900 sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$730K
45.0K sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

3
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Option exercise · 10b5-1 plan
M$149K
18.8K sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

3
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
3,760 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

2
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Option exercise
M—
7,187 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

2
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Derivative conversion
C—
7,187 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

2
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Derivative conversion
C—
7,187 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

1
HK
Hohenstein KenChief Revenue Officer
OSOneStream, Inc.
Option exercise · 10b5-1 plan
M$426K
40.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

1
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Open-market sale · 10b5-1 plan
SELL$13K
4,913 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

1
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$3,711
200 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$6,994
3,760 sh
Dec 18, 2025Dec 18, 2025
traded Dec 18, 2025
+0dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence

0
SS
Sharan SharatDirector, President and Chief Executive, 10% Owner
ONTFON24 INC.
Option exercise · 10b5-1 plan
M$49K
28.9K sh
Dec 17, 2025Dec 18, 2025
traded Dec 17, 2025
+1dSEC Form 4

Evidence

0
HK
Hohenstein KenChief Revenue Officer
OSOneStream, Inc.
Option exercise · 10b5-1 plan
M—
10.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence